Literature DB >> 15804242

Care needs and economic consequences after acute ischemic stroke: the Erlangen Stroke Project.

A Ward1, K A Payne, J J Caro, P U Heuschmann, P L Kolominsky-Rabas.   

Abstract

The objective was to determine the functional outcome, location of care and economic consequences in the first 3 months after ischemic stroke. As part of the Erlangen Stroke Project, (ESPro) information was collected on patients suffering a first-ever ischemic stroke. Three months after the stroke, location of care, dependence on caregivers and function based on Barthel Index: poor (0-55), moderate (60-90) or good function (95-100) were recorded. Data about health services used were combined with cost estimates for Germany (2000 Euros, undiscounted). Of 491 patients hospitalized, 383 were alive 3 months afterwards, 79% residing in the community. The majority of patients with poor function (60%) were still in institutional care. Patients with good function typically accrued the lowest costs, whether in an institution (17 965) or not (11 032) compared with poorer function who were living in an institution (poor: 26 370; moderate: 28,121), or community (poor: 27,207; moderate: 19,350). Hospitalization and rehabilitation services were the major costs accrued at each level of function. Many patients were left requiring a substantial amount of care and the costs associated with providing institutional care has a major impact on the economic consequences of a stroke.

Entities:  

Mesh:

Year:  2005        PMID: 15804242     DOI: 10.1111/j.1468-1331.2004.00949.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  12 in total

1.  [Development of mortality and morbidity of vascular diseases: variations between coronary heart disease and stroke].

Authors:  P U Heuschmann; H K Neuhauser; M Endres
Journal:  Nervenarzt       Date:  2011-02       Impact factor: 1.214

2.  [Anesthesia in the angiography suite : More than dancing in the dark].

Authors:  J-P Jantzen
Journal:  Anaesthesist       Date:  2013-09       Impact factor: 1.041

Review 3.  [New aspects of neurorehabilitation: motor and language].

Authors:  J Liepert; C Breitenstein
Journal:  Nervenarzt       Date:  2016-12       Impact factor: 1.214

4.  Costs of hospitalization for stroke patients aged 18-64 years in the United States.

Authors:  Guijing Wang; Zefeng Zhang; Carma Ayala; Diane O Dunet; Jing Fang; Mary G George
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-08-15       Impact factor: 2.136

5.  [Prevention of stroke: what is evidence based?].

Authors:  S Lüders; J Schrader
Journal:  Internist (Berl)       Date:  2009-12       Impact factor: 0.743

Review 6.  The global impact of non-communicable diseases on healthcare spending and national income: a systematic review.

Authors:  Taulant Muka; David Imo; Loes Jaspers; Veronica Colpani; Layal Chaker; Sven J van der Lee; Shanthi Mendis; Rajiv Chowdhury; Wichor M Bramer; Abby Falla; Raha Pazoki; Oscar H Franco
Journal:  Eur J Epidemiol       Date:  2015-01-18       Impact factor: 8.082

7.  Socioeconomic Inequalities in Health and Perceived Unmet Needs for Healthcare among the Elderly in Germany.

Authors:  Jens Hoebel; Alexander Rommel; Sara Lena Schröder; Judith Fuchs; Enno Nowossadeck; Thomas Lampert
Journal:  Int J Environ Res Public Health       Date:  2017-09-26       Impact factor: 3.390

8.  Influence of acute complications on outcome 3 months after ischemic stroke.

Authors:  Maike Miriam Grube; Hans-Christian Koennecke; Georg Walter; Andreas Meisel; Jan Sobesky; Christian Hans Nolte; Ian Wellwood; Peter Ulrich Heuschmann
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240

Review 9.  Microfabricated, amperometric, enzyme-based biosensors for in vivo applications.

Authors:  Andreas Weltin; Jochen Kieninger; Gerald A Urban
Journal:  Anal Bioanal Chem       Date:  2016-03-02       Impact factor: 4.142

10.  Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin.

Authors:  Vivek Y Reddy; Ronald L Akehurst; Shannon O Armstrong; Stacey L Amorosi; Nic Brereton; Deanna S Hertz; David R Holmes
Journal:  Europace       Date:  2016-02-02       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.